Citation Impact
Citing Papers
Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution
2009 Science
Marine natural products
1990 Standout
Signs and symptoms in common colds
1993
Antiviral activity of berberine and related compounds against human cytomegalovirus
2007
Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations
2009 Standout
Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach
2000 StandoutNobel
Anti‐human rhinovirus activity of gallic acid possessing antioxidant capacity
2010
The biochemistry and medical significance of the flavonoids
2002 Standout
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
2010 StandoutNobel
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
2016 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Use of the multiple copy simultaneous search (MCSS) method to design a new class of picornavirus capsid binding drugs
1997
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)
1989
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease
1999
A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
1996
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Anti-Human Rhinoviral Activity of Polybromocatechol Compounds Isolated from the Rhodophyta, Neorhodomela aculeata
2012
Cyclodextrin Drug Carrier Systems
1998 Standout
Synthesis and Evaluation of Antirhinovirus Activity of 3-Hydroxy and 3-Methoxy 2-Styrylchromones
2003
Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P1 Lactam Moieties as l -Glutamine Replacements
1999
Synthesis and Anti-Rhinovirus Properties of Fluoro-Substituted Flavonoids
2005
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
In vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1
1992
Anti-Picornavirus Activity of Synthetic Flavon-3-yl Esters
1998
Works of B. Dewindt being referenced
A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program
1991
Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization
1989
In vitro activity of R 61837, a new antirhinovirus compound
1988
Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity
1990
In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity
1992